DIgital Online SuPport for COVID-19 StrEss (DISPOSE)
COVID-19, Psychosocial Stress, Mental Health
About this trial
This is an interventional treatment trial for COVID-19 focused on measuring COVID-19, SARS-CoV-2, psychosocial stress, online support, guided, mental health, anxiety, depression, somatic symptom disorder
Eligibility Criteria
Inclusion criteria, general:
- Sufficient German language skills to participate in the assessments.
- Providing informed consent for participation.
Inclusion criteria for the arms "Online support program" and "Waiting condition...":
- Having signed up for the online support program provided by selfapy GmbH, Berlin, Germany (www.selfapy.de/corona) aiming at reducing burden in the context of the COVID-19 pandemic.
Inclusion criteria for the arm "No intervention...":
- Not having signed up for the online support program provided by selfapy GmbH, Berlin, Germany (www.selfapy.de/corona) aiming at reducing burden in the context of the COVID-19 pandemic.
Sites / Locations
- Selfapy GmbHRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
No Intervention
Online support program
Waiting period (WHO recommendation)
No intervention (natural course)
Guided online support program, consisting of modules (structured in chapters) aiming at reduce stress related to the COVID-19 pandemic.
Waiting period (2 weeks duration) during which subjects are provided with the WHO recommendations "Coping with stress during the 2019 nCoV outbreak". Following the 2 weeks waiting period, subjects are provided with the guided online support program outlined in the arm 'online support program'.
This non-randomised arm (recruited separately; anticipated sample size of 500 subjects, not counted in the overall anticipated sample size) consists of subjects not intending to participate in the Selfapy online support program. Assessment points in this arm are comparable to those in the arm "Online support program" (in the 'No intervention (natural course)' arm, T1 refers to time of study inclusion).